Belén Martinez-Madrid

Dr. Belén Martinez-Madrid

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2004 in The Lancet
Verified
Journal Article
Closed access
JDJ Donnez
J Donnez
MDMm Dolmans
Mm Dolmans
DDD Demylle
D Demylle
PJP Jadoul
P Jadoul
CPC Pirard
C Pirard
ALA Van Langendonckt
A Van Langendonckt

18 July 2006 in Human Reproduction Update
Verified
Journal Article
Open access
PDF file
JDJacques Donnez
Jacques Donnez
Belén Martinez-MadridBelén Martinez-Madrid
Belén Martinez-Madrid
PJPascale Jadoul
Pascale Jadoul
ALAnne Van Langendonckt
Anne Van Langendonckt
DDDominique Demylle
Dominique Demylle
MDMarie-Madeleine Dolmans
Marie-Madeleine Dolmans
The review covers current options for ovarian tissue cryopreservation and transplantation and provides a systematic review of the existing literature from the last 10 years, taking into account all previously published reviews on the subject. The different cryopreservation options available for fertility preservation in cancer patients are embryo cryopreservation, oocyte cryopreservation and ovarian tissue cryopreservation. The choice depends on various parameters: the type and timing of chemotherapy, the type of cancer, the patient’s age and the partner status. The different options and their results are discussed, as well as their putative indications and efficacy. The review concludes that advances in reproductive technology have made fertility preservation techniques a real possibility for patients whose gonadal function is threatened by premature menopause, or by treatments such as radiotherapy, chemotherapy or surgical castration.

1 August 2007 in Reproduction
Verified
Journal Article
Closed access
MDMarie-Madeleine Dolmans
Marie-Madeleine Dolmans
Belén Martinez-MadridBelén Martinez-Madrid
Belén Martinez-Madrid
EGElodie Gadisseux
Elodie Gadisseux
YGYves Guiot
Yves Guiot
WYWu Yuan Yuan
Wu Yuan Yuan
JDJacques Donnez
Jacques Donnez
This study was designed to evaluate follicular survival and growth after short-term transplantation of fresh isolated human follicles and ovarian cortical tissue to nude mice. Ovarian biopsies were obtained from nine women undergoing laparoscopy. Twelve nude mice were xenografted with an ovarian cortical fragment in the right ovarian bursa, and a clot containing isolated follicles in the left, for a period of 7 days. One ungrafted fragment was used as a control. Histological sections were analyzed to determine follicle number and stage. The proliferative status of follicular cells was assessed by Ki-67 immunostaining. A total of 659 follicles was analyzed by histology and 545 follicles by immunohistochemistry. The percentage of primordial follicles was found to be markedly reduced 1 week post-grafting when compared with ungrafted tissue, while the percentage of primary follicles had significantly increased. Only 8% of follicles showed Ki-67-positive granulosa cells before grafting, whereas 1 week after grafting, 71% of follicles in fragments and 67% of isolated follicles were Ki-67-positive (P<0.001). Moreover, the histological aspect of isolated follicle grafts was similar to that of grafted fragments: follicles were surrounded by vimentin-positive stroma-like tissue of human origin, as confirmed by fluorescent in situ hybridization with human-specific probes. Our results demonstrate, for the first time, that isolated human follicles are able to survive and grow after xenografting. This study also shows massive in vivo follicular activation after transplantation of grafted fragments and isolated follicles. One week after grafting, well-structured stroma-like tissue of human origin was observed around the isolated follicles. The potential origin of this stroma is discussed.

3 May 2007 in Human Reproduction
Verified
Journal Article
Open access
PDF file
CWChristine Wyns
Christine Wyns
MCMara Curaba
Mara Curaba
Belén Martinez-MadridBelén Martinez-Madrid
Belén Martinez-Madrid
ALAnne Van Langendonckt
Anne Van Langendonckt
WFWese François-Xavier
Wese François-Xavier
JDJacques Donnez
Jacques Donnez
Fertility preservation has become an urgent clinical requisite for prepubertal male cancer patients undergoing gonadotoxic treatment. As these patients do not yet produce spermatozoa for freezing, only immature tissue is available for storage. We studied the survival and proliferative activity of spermatogonia and Sertoli cells after cryopreservation of cryptorchid testicular tissue pieces followed by xenografting for 21 days. Single pieces of tissue from cryptorchid testes (2–9 mm3) of young boys (2–12 years) were cryopreserved, thawed and transplanted into the scrotum of mice. Quantitative morphometric and immunohistochemical techniques were used to evaluate the integrity of the tissue, as well as the survival and proliferative capacity of spermatogonia and Sertoli cells before and after freezing/thawing/grafting. Three weeks after grafting, cryopreserved tissue was removed and analysed. Most of the tubules (88.3%) were intact and there was no fibrosis or sclerosis, 14.5% of the initial spermatogonial population remained, as identified by the MAGE A4 antibody, and 32% of these cells showed proliferative activity evidenced by Ki67, compared to 17.8% before cryopreservation and grafting. The number of Sertoli cells was unchanged and 5.1% were Ki67-positive, compared to none at all before freezing and grafting. Through our orthotopic xenografting model, we have demonstrated the survival and proliferative activity of spermatogonia and Sertoli cells in cryopreserved immature human cryptorchid tissue. Testicular tissue banking may thus prove to be a promising technique for the preservation of fertility in prepubertal boys undergoing oncological treatments. As the stem cell niche is maintained, the cryopreserved tissue can potentially be used for future autotransplantation. In addition, whole tissue freezing does not exclude alternative clinical uses, including isolated cell transplantation after dissociation, selection and enrichment. However, as this work was done on cryptorchid tissue, studies on normal immature testicular tissue, involving longer grafting periods, are needed to demonstrate a differentiation capacity before clinical implementation. Ethical and safety issues should also be addressed.

1 November 2004 in Fertility and Sterility
Verified
Journal Article
Closed access
Belén Martinez-MadridBelén Martinez-Madrid
Belén Martinez-Madrid
MDMarie-Madeleine Dolmans
Marie-Madeleine Dolmans
ALAnne Van Langendonckt
Anne Van Langendonckt
SDSylvie Defrère
Sylvie Defrère
JDJacques Donnez
Jacques Donnez

30 September 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
MDMarie-Madeleine Dolmans
Marie-Madeleine Dolmans
NMNathalie Michaux
Nathalie Michaux
ACAlessandra Camboni
Alessandra Camboni
Belén Martinez-MadridBelén Martinez-Madrid
Belén Martinez-Madrid
ALAnne Van Langendonckt
Anne Van Langendonckt
JDJacques Donnez
Jacques Donnez
BACKGROUND: The purpose of this study is to evaluate the effectiveness of a standardized mixture of purified enzymes (Liberase), for the isolation of human ovarian follicles. METHODS: This is an experimental prospective study. Ovarian biopsies were obtained from eight young women undergoing laparoscopy for benign gynaecological disease. Follicles were isolated by Liberase or collagenase enzymatic digestion. Follicle quality was assessed by evaluating their general morphology and viability after fluorescent staining, and the ultrastructure by electron microscopy. RESULTS: The number of fully isolated follicles recovered from the Liberase-treated group was lower than from the collagenase group (156 versus 263) despite equal-sized biopsies being taken. A high proportion of follicles (98.6%, 70/71) were viable after Liberase isolation and most follicles were of good morphology with a complete granulosa cell layer (70.4%, 31/44). Ultrastructural studies indicated that Liberase-isolated follicles showed signs of atresia only occasionally and that the oolemma–follicular cell interface was well preserved. CONCLUSIONS: Liberase treatment allows the isolation of highly viable follicles from human ovarian tissue, with an unaltered morphology and ultrastructure. This purified endotoxin-free enzyme preparation is a promising alternative to impure collagenase preparations for the reproducible isolation of intact primordial and primary follicles for culture and grafting purposes.